Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Citigroup
C
5
Heico
HEI
JP Stock MarketDetailed Quotes
190A Chordia Therapeutics
- 232
- +3+1.31%
20min DelayMarket Closed May 8 15:30 JST
16.01BMarket Cap-7.46P/E (Static)
237High228Low510.30KVolume229Open229Pre Close118.97MTurnover93052wk High2.11%Turnover Ratio68.99MShares14252wk Low-31.2EPS TTM5.62BFloat Cap930Historical HighLossP/E (Static)24.21MShs Float142Historical Low-31.11EPS LYR3.93%Amplitude--Dividend TTM4.93P/B100Lot Size--Div YieldTTM
Chordia Therapeutics Key Stats
Chordia Therapeutics Q2 2025 Earnings Date
Currency：JPYApr 11, 2025
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| EPS | -- | -5.24 | -- |
-- | |||
| NI to Common Holders | -- | -360.00M | -- |
-- |
Analyst Rating
No Data
Chordia Therapeutics Earnings Estimates
Revenue
EPS
EBIT
No Data
Chordia Therapeutics Earnings Reports
Read more
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting